Background: Mineralocorticoid receptor antagonists (MRAs) improve outcomes in patients with heart failure and reduced ejection fraction (HFrEF). However, MRAs are often underused because of hyperkalemia concerns. Objectives: The purpose of this study was
Squire, Iain
core +1 more source
Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real‐World National Study
ABSTRACT Aims Evidence regarding the efficacy and safety of sodium–glucose cotransporter 2 inhibitors (SGLT2i) in monogenic diabetes is limited. We evaluated real‐world metabolic, renal, and safety outcomes of SGLT2i therapy in adults with monogenic diabetes.
Estelle Audrain +15 more
wiley +1 more source
Myocardial Histopathology-Based Heart Failure Phenotyping. [PDF]
Tersalvi G +9 more
europepmc +1 more source
LVEF-based phenotyping in very old adults hospitalised for heart failure: cardiological discrimination, shared geriatric burden, and treatment gaps. [PDF]
Esser R +10 more
europepmc +1 more source
Prognostic Value of Systemic Inflammatory Indices in Hospitalized Patients with HFrEF: A Multicenter Retrospective Cohort Study. [PDF]
Qiu Z, Cui P, Cai X, Wang R, Yang H.
europepmc +1 more source
Heart Failure Phenotypes Across Age Groups in the Danish Administrative Registers. [PDF]
Garred CH +6 more
europepmc +1 more source
Heart Failure with Reduced versus Preserved Ejection Fraction: Molecular Mechanisms, Immunologic Pathways, Current Therapies, and Future Directions. [PDF]
Kim E, Agrawal DK.
europepmc +1 more source
Correlation of Ankle-Brachial Index With NT-proBNP and Left Ventricular Ejection Fraction in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Cross-Sectional Study. [PDF]
Mahajan A +6 more
europepmc +1 more source
Obesity in Heart Failure: Mechanistic, Diagnostic and Therapeutic Considerations. [PDF]
Pathan F, Williams K.
europepmc +1 more source
Long-term efficacy and impact on rehospitalization of Qishen granules in patients with hypertension and heart failure with reduced ejection fraction: a multicenter, randomized, double-blind, placebo-controlled trial protocol. [PDF]
Zhang F +6 more
europepmc +1 more source

